NBQX is a selective and competitive antagonist of AMPA-type glutamate receptors. It exhibits neuroprotective and anticonvulsant properties, demonstrating efficacy in animal models. This compound is widely used in neuroscience research to study excitotoxicity, epilepsy, and synaptic transmission in both in vitro and in vivo systems.